BELLEVUE GROUP AG – Beam Therapeutics Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$27.23M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+23.07%
quarter
Beam Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.16% | -900 shares | 5.07M | $47.64 | 571.72K |
| Q2 2022 | share | Decrease | -1.75% | -10.2K shares | -11.23M | $38.71 | 572.62K |
| Q1 2022 | share | Decrease | -4.90% | -30K shares | -15.44M | $57.3 | 582.82K |
| Q4 2021 | share | 0.00% | 0 shares | -4.48M | $81.63 | 612.82K | |
| Q3 2021 | share | 0.00% | 0 shares | -25.55M | $87.01 | 612.82K | |
| Q2 2021 | share | Increase | +8.12% | 46K shares | 33.50M | $128.71 | 612.82K |
| Q1 2021 | share | Increase | +42.84% | 170K shares | 12.97M | $80.04 | 566.82K |
| Q4 2020 | share | Increase | 0.00% | 396.82K shares | 32.39M | $81.64 | 396.82K |